BIO joins the legal fight against Medicare pilot that ties drug prices to peer countries STAT 1d STAT 1d
Belfast biotech firm re-engages with global pharmaceutical business for ramp project Insider Media 3d Insider Media 3d
Amgen’s Repatha reduces heart attack risk in real-world study Clinical Trials Arena 2d Clinical Trials Arena 2d
Vir Biotechnology Announces Primary Endpoint Met in Pivotal Phase 3 eclipse 1 Trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta Business Wire (Press Release) 21:18
CIDEBsiRNA Normalizes Liver Fat and Improves Liver Injury Markers in MASLD Patients, as Highlighted at AASLD Regeneron Pharmaceuticals (Press Release) 21:01
Repatha Linked to 20% Lower Heart Attack Rate Than Ezetimibe in 544,000-Patient Study Medical Daily 17:50 Sat, 07 Nov
BIO joins the legal fight against Medicare pilot that ties drug prices to peer countries STAT 17:01 Sat, 07 Nov
Concord Biotech: Recovering business momentum and new ventures support growth The Hindu Business Line 16:20 Sat, 07 Nov